Company search
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Data as at: 15/07/2026
In
Objective
To provide absolute returns by investing in an actively managed portfolio of equities and derivatives with exposure to the global healthcare market.
AIC sector
Management group
Launch date
02/12/2016
November
Domicile
United Kingdom
Fund manager
Kosta Kleyman
Dividend frequency
Semi-Annually
Wind-up provisions
There are no specific provisions for the termination of the life of the Company.
| Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
|---|---|---|---|---|---|---|---|---|
| 65.34 | 68.31 | 140.00 | 146.38 | -4.36 | 0 | 3.86 | Feb, Jul | 1.34 (30/11/2025) |
Scroll
Dividends
Dividends declared in last 12 months
| Ex-dividend date | Payment date | Dividend amount | Special dividend | Financial year |
|---|---|---|---|---|
| 07/05/2026 | 29/05/2026 | 2.700 | No | 2025 |
| 14/08/2025 | 12/09/2025 | 2.700 | No | 2025 |
Scroll
Performance (%)
| Return type | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| CT Healthcare Trust | Share price total return | 17.6 | 2.9 | -16.2 | N/A |
| Healthcare & Biotechnology AIC sector | Share price total return | 37.5 | 23.1 | -1.1 | 98.8 |
Scroll
Share structure
Number of shares
46,669,520
268,482,789
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 372,003 | 3,232,087 | 216,243,109 | 1,559,716,415 |
| Average | N/A | 146,913 | 854,716 | 1,236,890 |
Scroll
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 0.52 | 4.37 | 273.78 | 2,284.33 |
| Average | N/A | 0.20 | 1.08 | 1.81 |
Scroll
Trading details
| ISIN | Ticker | Traded currency | Stock exchange |
|---|---|---|---|
| GB00BZCNLL95 | CTHT | GBX | London Stock Exchange - MAIN |
Scroll
Top holdings
Data as at : 30/11/2025
| Investment | % of total assets |
|---|---|
| Natera | 5.1 |
| Regeneron Pharmaceuticals | 5.0 |
| Iqvia | 4.6 |
| Care Dx | 4.3 |
| UnitedHealth Group Inc | 4.1 |
| Thermo Fisher | 3.7 |
| Abb Vie | 3.6 |
| Insulet | 3.4 |
| Structure Therapeutics | 3.4 |
| Astra Zeneca | 3.2 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
